Analysen von Richard Vosser
| 04.04.22 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 18.02.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 14.02.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 11.02.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 09.02.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 08.02.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 04.02.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 03.02.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 03.02.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 02.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 02.02.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 01.02.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 01.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 31.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 31.01.22 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 26.01.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 26.01.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 26.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 25.01.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 24.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 20.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 13.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 13.01.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 13.01.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 12.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 12.01.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 04.01.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 04.01.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 04.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.01.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.01.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 04.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 04.01.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 04.01.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 04.01.22 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 04.01.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 20.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.12.21 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 16.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.12.21 | Merck Overweight | JP Morgan Chase & Co. | |
| 13.12.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 10.12.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 10.12.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 03.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 02.12.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 01.12.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 26.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.11.21 | Merck Overweight | JP Morgan Chase & Co. | |
| 11.11.21 | Merck Overweight | JP Morgan Chase & Co. | |
| 10.11.21 | Bayer Overweight | JP Morgan Chase & Co. | |